McKesson Corporation (MCK): are the analysts right?

McKesson Corporation · Health Care · ref. ETF XLV · 52 calls · price $807.33
What the company does: McKesson fournit des services pharmaceutiques, oncologiques et médico-chirurgicaux aux États-Unis et internationalement.
📈 1-year price
$807.33+11.5% over range
Jul 8, 25low $659.01 · high $995.69Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
80% recommend buying · 10 analysts

🎯 Analyst price target on MCK

High target · 1 analyst$1050+30.1%
Median target · 9 analysts$945+17.1%
Low target · 1 analyst$812+0.6%
Current price$807.33

🗳️ The analyst consensus

Analyst breakdown · 10 (6 months)
Strong Buy0%
Buy80%
Hold20%
Sell0%
Strong Sell0%

💰 McKesson Corporation dividend

0.43%annual yield
📈 Steady dividend18 yrs of consecutive dividend increases
That's ~$3.28 per share per year.

✅ Historical analyst reliability on MCK

Most reliable analysts on MCK (% profitable · 365j · ≥2 calls)
Leerink Partners 100% +46.7% 2
Citigroup 100% +39.6% 2
B of A Securities 100% +23.6% 3
Morgan Stanley 100% +22.9% 3

📊 What $1,000 invested in McKesson Corporation would be worth

In short — $1,000 invested in McKesson Corporation 10 years ago would be worth $3,831 today, i.e. +14%/yr on average. Best year: 2022 (+51%), worst: 2018 (-29%). Price performance, excluding dividends.

If I'd invested $1,000 in McKesson Corporation

InvestmentWorth todayGain
1 years ago$1,326+33%
3 years ago$2,014+101%
5 years ago$4,345+334%
10 years ago$3,831+283%
since inception (1994)$46,320+4532%

Return by year (McKesson Corporation)

YearReturn$1,000 invested at year start
2026 (YTD)-8%$921 (-8%)
2025+44%$1,326 (+33%)
2024+23%$1,632 (+63%)
2023+23%$2,014 (+101%)
2022+51%$3,040 (+204%)
2021+43%$4,345 (+334%)
2020+26%$5,463 (+446%)
2019+25%$6,840 (+584%)
2018-29%$4,845 (+385%)
2017+11%$5,380 (+438%)
2016-29%$3,831 (+283%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance💰 Dividend
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on MCK

Barclays
Jun 10, 26
▲ Overweight · 🎯$925
Price at call : $787.19 — upside +18%
Today : $807.33 — upside +15%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Jun 10, 27
Citigroup
May 14, 26
▲ Buy · 🎯$945
Price at call : $760.57 — upside +24%
Today : $807.33 — upside +17%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : May 14, 27
Wells Fargo
May 12, 26
■ Equal-Weight neutral · not a buy · 🎯$812
Price at call : $734.69 — gap to target +11%
Today : $807.33 — gap to target +1%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : May 12, 27
UBS
May 8, 26
▲ Buy · 🎯$1050
Price at call : $725.17 — upside +45%
Today : $807.33 — upside +30%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : May 8, 27
JP Morgan
May 8, 26
▲ Overweight · 🎯$1015
Price at call : $725.17 — upside +40%
Today : $807.33 — upside +26%
🎯 on MCK : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : May 8, 27
▲ Outperform · 🎯$850
Price at call : $725.17 — upside +17%
Today : $807.33 — upside +5%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : May 8, 27
William Blair
Apr 28, 26
▲ Outperform
🎯 on MCK : no call matured yet · 📊 on Health : 65.4% · +5.6% (26 calls)
in progress (365j)
matures : Apr 28, 27
UBS
Apr 22, 26
▲ Buy · 🎯$1000
Price at call : $836.1 — upside +20%
Today : $807.33 — upside +24%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Apr 22, 27
▲ Outperform · 🎯$950
Price at call : $873.43 — upside +9%
Today : $807.33 — upside +18%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Apr 8, 27
▲ Buy · 🎯$1000
Price at call : $856.62 — upside +17%
Today : $807.33 — upside +24%
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Apr 6, 27
Barclays
Feb 18, 26
▲ Overweight · 🎯$1050
Price at call : $937.14 — upside +12%
Today : $807.33 — upside +30%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Feb 18, 27
JP Morgan
Feb 10, 26
▲ Overweight · 🎯$1107
Price at call : $953.19 — upside +16%
Today : $807.33 — upside +37%
🎯 on MCK : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Feb 10, 27
TD Cowen
Feb 5, 26
▲ Buy · 🎯$1012
Price at call : $948.68 — upside +7%
Today : $807.33 — upside +25%
🎯 on MCK : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Feb 5, 27
Wells Fargo
Feb 5, 26
■ Equal-Weight neutral · not a buy · 🎯$925
Price at call : $957.8 — gap to target -3%
Today : $807.33 — gap to target +15%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Feb 5, 27
Mizuho
Feb 5, 26
■ Neutral neutral · not a buy · 🎯$885
Price at call : $957.8 — gap to target -8%
Today : $807.33 — gap to target +10%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Feb 5, 27
Barclays
Dec 9, 25
▲ Overweight · 🎯$960
Price at call : $813.1 — upside +18%
Today : $807.33 — upside +19%
🎯 on MCK : no call matured yet · 📊 on Health : 50.1% · +2.2% (617 calls)
in progress (365j)
matures : Dec 9, 26
Wells Fargo
Nov 10, 25
■ Equal-Weight neutral · not a buy · 🎯$914
Price at call : $859.37 — gap to target +6%
Today : $807.33 — gap to target +13%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Nov 10, 26
UBS
Nov 6, 25
▲ Buy · 🎯$980
Price at call : $851.99 — upside +15%
Today : $807.33 — upside +21%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Nov 6, 26
Baird
Nov 6, 25
▲ Outperform · 🎯$927
Price at call : $851.99 — upside +9%
Today : $807.33 — upside +15%
🎯 on MCK : no call matured yet · 📊 on Health : 52.3% · +7.1% (287 calls)
in progress (365j)
matures : Nov 6, 26
▲ Overweight · 🎯$916
Price at call : $851.99 — upside +8%
Today : $807.33 — upside +13%
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Nov 6, 26
UBS
Oct 27, 25
▲ Buy · 🎯$920
Price at call : $804.59 — upside +14%
Today : $807.33 — upside +14%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Oct 27, 26
Jefferies
Oct 14, 25
▲ Buy · 🎯$900
Price at call : $781.9 — upside +15%
Today : $807.33 — upside +11%
🎯 on MCK : no call matured yet · 📊 on Health : 50.5% · +4.5% (376 calls)
in progress (365j)
matures : Oct 14, 26
JP Morgan
Sep 26, 25
▲ Overweight · 🎯$853
Price at call : $760.55 — upside +12%
Today : $807.33 — upside +6%
🎯 on MCK : no call matured yet · 📊 on Health : 53.6% · +5.2% (349 calls)
in progress (365j)
matures : Sep 26, 26
▲ Outperform · 🎯$825
Price at call : $736.52 — upside +12%
Today : $807.33 — upside +2%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Sep 24, 26
TD Cowen
Sep 24, 25
▲ Buy · 🎯$864
Price at call : $736.52 — upside +17%
Today : $807.33 — upside +7%
🎯 on MCK : no call matured yet · 📊 on Health : 48.4% · +0.8% (95 calls)
in progress (365j)
matures : Sep 24, 26
Citigroup
Sep 24, 25
▲ Buy · 🎯$860
Price at call : $736.52 — upside +17%
Today : $807.33 — upside +7%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
in progress (365j)
matures : Sep 24, 26
Mizuho
Sep 24, 25
■ Neutral neutral · not a buy · 🎯$770
Price at call : $736.52 — gap to target +5%
Today : $807.33 — gap to target -5%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Sep 24, 26
▲ Overweight · 🎯$857
Price at call : $760.58 — upside +13%
Today : $807.33 — upside +6%
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Sep 24, 26
Deutsche Bank
Sep 24, 25
▲ Buy · 🎯$856
Price at call : $760.58 — upside +13%
Today : $807.33 — upside +6%
🎯 on MCK : no call matured yet · 📊 on Health : 53.3% · +4.4% (289 calls)
in progress (365j)
matures : Sep 24, 26
Wells Fargo
Sep 24, 25
■ Equal-Weight neutral · not a buy · 🎯$816
Price at call : $760.58 — gap to target +7%
Today : $807.33 — gap to target +1%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Sep 24, 26
▲ Outperform · 🎯$850
Price at call : $760.58 — upside +12%
Today : $807.33 — upside +5%
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
in progress (365j)
matures : Sep 24, 26
UBS
Sep 24, 25
▲ Buy · 🎯$860
Price at call : $760.58 — upside +13%
Today : $807.33 — upside +7%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
in progress (365j)
matures : Sep 24, 26
▲ Buy · 🎯$850
Price at call : $760.58 — upside +12%
Today : $807.33 — upside +5%
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
in progress (365j)
matures : Sep 24, 26
Wells Fargo
Aug 13, 25
■ Equal-Weight neutral · not a buy · 🎯$772
Price at call : $663.17 — gap to target +16%
Today : $807.33 — gap to target -4%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Aug 13, 26
▲ Overweight · 🎯$810
Price at call : $715.74 — upside +13%
Today : $807.33 — upside +0%
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
in progress (365j)
matures : Jul 16, 26
▲ Outperform · 🎯$800
Price at call : $727.23 — upside +10%
Today : $807.33 — upside -1%
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
in progress (365j)
matures : Jul 9, 26
▲ Overweight · 🎯$770
Price at call : $730.8 — upside +5%
Today : $807.33 — upside -5%
Expected +5% · Actual +7% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+7.3%
stock +7% · XLV +12%
Wells Fargo
Jun 3, 25
■ Equal-Weight neutral · not a buy · 🎯$766
Price at call : $714.88 — gap to target +7%
Today : $807.33 — gap to target -5%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Jun 3, 26
▲ Buy · 🎯$800
Price at call : $693.46 — upside +15%
Today : $807.33 — upside -1%
Expected +15% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+4.6%
stock +5% · XLV +8%
UBS
Apr 29, 25
▲ Buy · 🎯$805
Price at call : $712.79 — upside +13%
Today : $807.33 — upside -0%
Expected +13% · Actual +14% · Reason (≥ +15%) : ✗ No
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 52.1% · +3.4% (340 calls)
+14.4%
stock +14% · XLV +4%
▲ Buy · 🎯$755
Price at call : $689.36 — upside +10%
Today : $807.33 — upside -6%
Expected +10% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+25.4%
stock +25% · XLV +8%
Mizuho
Apr 3, 25
■ Neutral neutral · not a buy · 🎯$690
Price at call : $683.11 — gap to target +1%
Today : $807.33 — gap to target -15%
🎯 on MCK : no call matured yet · 📊 on Health : 53.8% · +4.4% (208 calls)
in progress (365j)
matures : Apr 3, 26
▲ Overweight · 🎯$745
Price at call : $716.93 — upside +4%
Today : $807.33 — upside -8%
Expected +4% · Actual +20% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+19.5%
stock +20% · XLV +2%
Wells Fargo
Mar 14, 25
■ Equal-Weight neutral · not a buy · 🎯$691
Price at call : $655.25 — gap to target +5%
Today : $807.33 — gap to target -14%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Mar 14, 26
▲ Outperform · 🎯$675
Price at call : $595.69 — upside +13%
Today : $807.33 — upside -16%
Expected +13% · Actual +62% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (1 call matured) · 📊 on Health : 47.6% · +1.3% (147 calls)
+61.6%
stock +62% · XLV +7%
Citigroup
Jan 10, 25
▲ Buy · 🎯$677
Price at call : $585.08 — upside +16%
Today : $807.33 — upside -16%
Expected +16% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
+41.1%
stock +41% · XLV +11%
▲ Buy · 🎯$650
Price at call : $585.24 — upside +11%
Today : $807.33 — upside -19%
Expected +11% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 48.6% · +2.3% (352 calls)
+40.8%
stock +41% · XLV +14%
▲ Overweight · 🎯$642
Price at call : $570.98 — upside +12%
Today : $807.33 — upside -20%
Expected +12% · Actual +42% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (3 calls matureds) · 📊 on Health : 51.7% · +5.3% (804 calls)
+42.0%
stock +42% · XLV +12%
Wells Fargo
Dec 13, 24
■ Equal-Weight neutral · not a buy · 🎯$641
Price at call : $570.07 — gap to target +12%
Today : $807.33 — gap to target -21%
🎯 on MCK : no call matured yet · 📊 on Health : 49.3% · +2.1% (371 calls)
in progress (365j)
matures : Dec 13, 25
Citigroup
Nov 13, 24
▲ Buy · 🎯$713
Price at call : $610.16 — upside +17%
Today : $807.33 — upside -12%
Expected +17% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 53.4% · +2.8% (496 calls)
+38.0%
stock +38% · XLV +5%
▲ Outperform · 🎯$630
Price at call : $483.67 — upside +30%
Today : $807.33 — upside -22%
Expected +30% · Actual +55% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
+55.1%
stock +55% · XLV -4%
▲ Outperform · 🎯$665
Price at call : $504.17 — upside +32%
Today : $807.33 — upside -18%
Expected +32% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on MCK : 100% (2 calls matureds) · 📊 on Health : 57.1% · +6.2% (35 calls)
+38.2%
stock +38% · XLV -10%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)